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Abstract
Objective:  this  study  aimed  to  review  the  literature  regarding  late  preterm  births  (34  weeks
to 36  weeks  and  6  days  of  gestation)  in  its  several  aspects.
Sources:  the  MEDLINE,  LILACS,  and  Cochrane  Library  databases  were  searched,  and  the  refer-
ences  of  the  articles  retrieved  were  also  used,  with  no  limit  of  time.
Data synthesis:  numerous  studies  showed  a  recent  increase  in  late  preterm  births.  In  all  series,
late preterm  comprised  the  majority  of  preterm  births.  Studies  including  millions  of  births
showed  a  strong  association  between  late  preterm  birth  and  neonatal  mortality.  A  higher  mor-
tality  in  childhood  and  among  young  adults  was  also  observed.  Many  studies  found  an  association
with  several  neonatal  complications,  and  also  with  long-term  disorders  and  sequelae:  breast-
feeding  problems,  cerebral  palsy,  asthma  in  childhood,  poor  school  performance,  schizophrenia,
and  young  adult  diabetes.  Some  authors  propose  strategies  to  reduce  late  preterm  birth,  or  to
improve  neonatal  outcome:  use  of  antenatal  corticosteroids,  changes  in  some  of  the  guidelines
for  early  delivery  in  high-risk  pregnancies,  and  changes  in  neonatal  care  for  this  group.
Conclusions: numerous  studies  show  greater  mortality  and  morbidity  in  late  preterm  infants
compared with  term  infants,  in  addition  to  long-term  disorders.  More  recent  studies  evaluated
strategies  to  improve  the  outcomes  of  these  neonates.  Further  studies  on  these  strategies  are
needed.
©  2014  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  
Este é um artigo Open Access sob a licença de CC BY-NC-NDPALAVRAS-CHAVE Prematuridade  tardia:  uma  revisão  sistemática
Trabalho  de  parto
prematuro;
Mortalidade  neonatal
precoce;
Resumo
Objetivo:  revisar  a  literatura  sobre  prematuridade  tardia  (nascimentos  de  34  semanas  a  36
semanas  e  seis  dias)  em  seus  vários  aspectos.
 Please cite this article as: Machado LC Jr, Passini R Jr, Rosa IR. Late prematurity: a systematic review. J Pediatr (Rio J). 2014;90:221--31.
 Study conducted at the Universidade Estadual de Campinas(UNICAMP).
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Mortalidade
neonatal;
Mortalidade  infantil;
Gravidez de  alto  risco
Fonte  dos  dados:  buscas  nas  bases  MEDLINE,  LILACS  e  Biblioteca  Cochrane,  sem  limite  de
tempo, e  nas  referências  bibliográficas  dos  artigos  encontrados.
Síntese  dos  dados: muitos  estudos  mostram  aumento  na  taxa  de  prematuridade  tardia  nos
últimos anos.  Em  todas  as  séries,  os  prematuros  tardios  correspondem  à  maioria  dos  nasci-
mentos  prematuros.  Estudos  envolvendo  análises  de  milhões  de  nascimentos  comprovam  a
forte  associac¸ão  entre  prematuridade  tardia  e  mortalidade  neonatal.  Também  se  observou
associac¸ão  com  maior  mortalidade  infantil  e  no  adulto  jovem.  Muitos  estudos  encontraram
associac¸ão com  várias  complicac¸ões  neonatais  e  com  problemas  e  sequelas  de  longo  prazo,
tais  como:  dificuldades  na  amamentac¸ão,  paralisia  cerebral,  asma  na  infância,  pior  desem-
penho  escolar,  esquizofrenia  e  diabetes  no  adulto  jovem.  Alguns  autores  propõem  estratégias
para  reduzir  a  incidência  desses  nascimentos  ou  para  melhorar  seus  resultados:  utilizac¸ão  de
corticosteroides  antenatais;  mudanc¸a em  rotinas  de  interrupc¸ão  de  gestac¸ões  de  alto  risco;
mudanc¸as  nos  cuidados  neonatais.
Conclusões: muitos  estudos  mostram  maior  morbidade  e  mortalidade  nos  prematuros  tardios
comparados aos  recém-nascidos  a  termo,  além  de  sequelas  e  complicac¸ões  de  longo  prazo.
Estudos  mais  recentes  avaliam  estratégias  para  melhorar  o  prognóstico  destes  recém-nascidos.
Novos  estudos  com  este  objetivo  são  bem-vindos.
©  2014  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
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reterm  birth,  defined  as  birth  before  37  full  weeks,  remains
he leading  cause  of  death  and  complications  in  the  neonatal
eriod and  a  major  cause  of  these  outcomes  in  childhood.
owever, clinical  investigations  have  traditionally  focused
n premature  infants  born  at  a  gestational  age  (GA)  of
2 weeks  or  less,  which  are  obviously  at  greatest  risk.  Only
ecently preterm  infants  with  GA  >  33  or  34  weeks  have  been
valuated more  carefully.  In  practice,  newborns  with  GA  of
4 to  36  weeks  and  six  days  tend  to  be  considered,  both
y obstetricians  and  neonatologists,  as  having  a  very  similar
isk to  those  born  at  term.
This  attitude  is  reflected  in  the  obstetrician’s  routine,
or instance,  regarding  the  greater  tolerance  toward  inter-
upting the  pregnancy  when  there  are  maternal  and/or
etal complications  from  34  weeks  on,1 as  well  as  in  the
eonatologist’s routine,  regarding  the  tendency  to  keep
hese newborns  in  low-risk  nurseries  or  rooming-in  care2
nd  provide  early  discharge.3 These  practices  are  due,  at
east in  part,  to  results  of  studies  by  Goldenberg  et  al.4 and
y De  Palma  et  al.5 These  authors  evaluated  the  gain  for
ach additional  week  of  gestation  between  22  and  37  weeks
n increased  survival  and  decreased  risk  of  complications
nd/or sequelae.  They  observed  that  the  benefits  become
ess important  and  more  difficult  to  detect  from  33  to  34
eeks on.  However,  these  authors  did  not  compare  these
esults with  those  of  children  born  at  term.
More  recent  studies  have  shown,  however,  that  despite
aving a  lower  risk  than  premature  infants  with  lower  GA,
reterm infants  born  between  34  and  36  weeks  have  a  much
igher risk  of  death  and  complications  than  those  born  at
erm. Moreover,  as  the  number  of  births  at  this  GA  is  greater
han at  younger  ages,  the  absolute  number  of  deaths  and
omplications may  also  be  higher.  The  concern  regarding
hese findings  led  the  National  Institute  of  Child  Health
nd Human  Development  of  the  United  States  to  organize
b working  group  to  study  this  theme.6 At  this  meeting,  it
as decided  that  infants  born  at  34  to  36  weeks  and  six  days
f GA  would  be  called  late  preterm  infants.
bjectives
his  review  aims  to  investigate  studies  about  late  prema-
urity, regardless  of  the  issues  addressed,  also  including
tudies that  evaluated  strategies  to  reduce  the  incidence
nd the  unfavorable  outcomes  caused  by  this  condition.
ethods
earches  were  performed  until  December  of  2012  in  the
ollowing databases  using  the  keywords  listed  below:
MEDLINE  --  late  preterm  mortality,  late  preterm  morbid-
ity, late  prematurity  mortality,  late  prematurity  morbidity,
late  preterm  (always  using  the  conjunction  ‘‘and’’).
LILACS  --  prematuridade  tardia  mortalidade,  prematuri-
dade tardia  morbidade,  prematuro  tardio  mortalidade,
prematuro tardio  morbidade,  prematuro  tardio,  prema-
turidade  tardia,  as  well  as  those  in  English  used  in  MEDLINE
(always  using  the  conjunction  ‘‘and’’).
Cochrane Library:  late  and  preterm.  The  references  of  the
articles  retrieved  were  also  searched.
To  choose  the  studies  for  discussion,  preference  was
iven to  studies  with  the  following  characteristics:a) meta-analysis  studies;
)  studies  that  excluded  malformations  and  made  adjust-
ments  for  confounding  variables;
c) studies  with  larger  sample  sizes;
p
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d)  studies  addressing  specific  aspects  of  the  subject,  not
evaluated  by  others,  including  review  articles  with  this
characteristic;
e)  studies  conducted  in  Brazil;
Case series  studies,  i.e.,  non-analytical  studies,  as  well
as studies  in  languages  other  than  English,  Portuguese,  or
Spanish were  excluded.
Results
A  total  of  307  articles  addressing  the  topic  were  retrieved,
with 213  original  studies  (206  in  MEDLINE  and  seven  in
LILACS) and  94  review  articles,  letters,  or  editorials  (all  in
MEDLINE). The  results  of  the  65  selected  studies  are  shown
below, grouped  into  topics.
a)  General  aspects:  There  were  no  articles  published
before 2000,  and  most  were  published  after  2005.
There  were  few  Brazilian  studies.  Almeida  et  al.7
assessed  neonatal  resuscitation  in  several  regions  of  Brazil
and observed  the  need  for  resuscitative  measures  in  43.5%
of late  preterm  infants  (LPTIs).  Ortigosa  et  al.8 compared
the group  of  LPTI  with  restricted  growth,  who  were  born  by
scheduled cesarean  section,  indicated  by  maternal  and/or
fetal diseases,  with  another  group  of  preterm  infants  with
normal growth,  without  risk  factors  and  born  after  sponta-
neous labor.  A  higher  rate  of  complications  was  found  in  the
first group,  with  the  following  means:  phototherapy  (5.78
versus 3.19  days,  p  =  0.005),  admission  to  neonatal  inten-
sive care  unit  (NICU)  (5.92  versus  1.28  days;  p  <  0.0001),
hospital length  of  stay  (16.36  versus  4.58  days,  p  =  0.0001),
hypoglycemia (24%  versus  6%,  p  =  0.047),  and  intraventricu-
lar hemorrhage  (12%  versus  0%,  p  =  0.037).  They  concluded
that preterm  infants  with  restricted  growth  are  at  higher  risk
than those  without  this  condition.  The  authors,  however,  did
not control  for  confounding  variables.
Barros  et  al.9 found  a  higher  frequency  of  abnormal
results in  a  neurobehavioral  examination  performed  in  the
first 24  to  72  hours  of  life.  Kao  et  al.10 studied  aspects  of
LPTI behavior  related  to  the  capacity  to  breastfeed,  observ-
ing a  significantly  lower  capacity  when  compared  to  infants
born at  term.  Santos  et  al.,11 studying  a  cohort  of  children
born in  2004  in  the  city  of  Pelotas,  state  of  Rio  Grande  do
Sul, Brazil,  performed  two  studies.
Porto  et  al.12 performed  a  clinical  trial  to  evaluate  the
effect of  antenatal  corticosteroid  use  on  LPTI.  Araújo  et  al.13
studied  mortality  and  morbidity.  These  latter  four  studies
are described  elsewhere  in  this  text.  The  remaining  studies
were conducted  in  other  countries.
Teune  et  al.14 carried  out  the  only  meta-analysis  found  in
this review,  encompassing  more  than  29  million  births.  Their
results are  discussed  in  subsequent  sections  of  this  article.
Suzuki et  al.15 found  no  difference  in  neonatal  outcome  in
LPTI resulting  from  dichorionic  twin  pregnancies  compared
with singleton  pregnancies.  Refuerzo  et  al.16 studied  neona-
tal complications  in  multiple  pregnancies  only,  comparing
LPTI with  those  born  at  term.  They  studied  an  outcome
consisting of  one  or  more  of  the  following  events:  neona-
tal death,  hyaline  membrane  disease,  sepsis,  necrotizing
enterocolitis, bronchopulmonary  dysplasia,  intraventricular
hemorrhage, periventricular  leukomalacia,  retinopathy,  and
s
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neumonia.  They  found  a  relative  risk  (RR)  of  24.9  (95%  CI:
.8-732.2) for  LPTI.
A  traditional  concept  in  obstetrics  is  that  once  lung  matu-
ity is  detected  by  tests  performed  in  the  amniotic  fluid,
he possibility  of  significant  problems  in  the  newborn  is
nlikely. Some  recent  studies,  however,  have  relativized  this
oncept. Kamath  et  al.17 showed  a  higher  frequency  of  sup-
lemental oxygen  with  an  odds  ratio  (OR)  of  19.14  (95%
I: 1.62-226),  phototherapy  (OR:  6.67;  95%  CI:  1.52-29),
nd hypoglycemia  (OR:  3.95;  95%  CI:  1.76  to  8.85)  in  LPTI
nfants with  confirmatory  lung  maturity  tests,  in  comparison
o those  born  at  term.  The  authors  evaluated  three  differ-
nt tests:  lecithin/sphingomyelin,  phosphatidylglycerol,  and
amellar body  count,  and  the  assumed  maturity  criterion  was
oncomitant positivity  in  the  three  tests.
Bates  et  al.18 compared  459  newborns  with  36  to  38
eeks and  six  days  of  GA,  all  with  positive  maturity  tests
lecithin/sphingomyelin  ratio  ≥  2  and  ≥  3.5  for  diabetic
others), with  13,339  newborns  with  39  or  40  weeks  of
A whose  mothers  were  not  submitted  to  these  tests.
hey studied  a  composite  outcome  consisting  of  neona-
al death,  respiratory  morbidity,  hypoglycemia,  jaundice
equiring treatment,  seizures,  necrotizing  enterocolitis,
ypoxic-ischemic encephalopathy,  periventricular  leukoma-
acia, and  sepsis,  and  observed  an  adjusted  OR  of  1.7  (95%
I: 1.1-3.5)  for  pregnancies  lasting  less  than  39  weeks.  For
yaline membrane,  they  found  an  OR  of  7.6  (95%  CI:  2.2-
6.6).
Tennant et  al.19 assessed  the  frequency  of  hyaline  mem-
rane and  transient  tachypnea  from  34  to  39  weeks  using
 sequence  of  lung  maturity  tests.  At  their  institution,
n the  event  of  a negative  or  inconclusive  result  (surfac-
ant/albumin ratio),  a second  test  is  conducted,  which
an be  phosphatidylglycerol  or  lecithin/sphingomyelin
atio. Respiratory  complications  were  observed  in  38.9%
ases in  which  lung  maturity  was  confirmed  by  the
ecithin/sphingomyelin  ratio  as  the  second  test.  These
tudies demonstrate  that  laboratory  confirmation  of  lung
aturity does  not  guarantee  the  absence  of  respiratory
roblems, and  that  the  immaturity  of  other  systems  can  also
ause significant  neonatal  complications.
Lisinkova  et  al.20 performed  a  large,  ecological-type
tudy including  national  data  for  the  year  2004  in  the  United
tates, Canada,  and  26  European  countries.  They  showed
hat in  countries  where  the  rate  of  LPTI  was  higher,  there
as a  lower  rate  of  stillbirths  and  neonatal  deaths.  They
bserved that  for  a 1%  increase  in  the  rate  of  births  between
2 and  37  weeks,  there  was  decrease  in  intrauterine  deaths
ver 32  weeks,  measured  by  an  adjusted  OR  of  0.94  (95%
I: 0.92-0.96).  The  same  increase  was  associated  with  a
eduction in  neonatal  deaths  over  32  weeks  (adjusted  OR:
.88, 95%  CI:  0.85-0.91),  of  intrauterine  deaths  at  37  or  more
eeks (adjusted  OR:  0.88,  95%  CI:  0.85-0.91),  and  neonatal
eaths at  37  or  more  weeks  (adjusted  OR:  0.82,  95%  CI:  0.78-
.86). The  authors’  argument  was  that  the  births  resulting
rom medical  interruption  in  this  range  (32  to  37  weeks)  are
sually beneficial,  because  they  were  generally  performed
n fetuses  or  newborns  who  would  have  otherwise  died.Therefore,  despite  the  large  number  of  studies  demon-
trating the  greater  risks  of  late  preterm  births  when
ompared to  full  term  births,  they  argue  that  children  born
fter pregnancy  interruption  at  this  stage  could  not  be
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ompared  to  those  born  at  full  term,  as  they  would  be,
oth in  utero  and  in  neonatal  life,  at  greater  risk,  and  that
he intervention  would  have  a  protective  role.  There  would
e an  indication  bias,  and  an  ecological  study  would  be  an
lternative to  overcome  this  bias.21
Similarly,  Joseph  et  al.22 argued  that  the  evaluation  of
eonatal outcome  of  pregnancy  interruptions  should  be  per-
ormed within  the  specific  risk  group.  In  that  study,  they
resent U.S.  national  data  comparing  the  years  1996-1997
ith 2004-2005,  in  the  population  of  children  born  to  women
ith hypertension.  There  was  an  increase  in  births  at  34  to
6 weeks,  which  was  concomitant  with  a  decrease  in  neona-
al mortality  at  this  same  range.  They  also  showed  data
rom other  countries,  disclosing  similar  results.  Therefore,
hey argued  that  increases  in  interruptions  in  this  range  that
ave been  reported  recently  have  been  generally  benefi-
ial. Their  arguments,  similar  to  those  of  Lisinkova  et  al.,20
re  based  on  ecological  analysis,  that  is,  analysis  comparing
opulations, rather  than  individuals.
) Frequency  and  temporal  trend:  the  frequency  of  LPTI  in
relation  to  total  births  depends  on  the  type  of  institution
where the  study  is  performed,  and  it  is  higher  in  tertiary
care centers.  In  all  series,  however,  LPTI  correspond  to
the  majority  of  preterm  infants.  Furzán  and  Sanchez,23
McIntire  et  al.,24 and  Guasch  et  al.25 observed  that,  of
the  population  of  premature  infants,  63.2%,  76%,  and  79%
were  LPTI,  respectively.  Carter  et  al.26 found  a  preva-
lence of  9%  of  preterm  births  for  the  entire  United  States
from  2000  to  2006,  and  the  LPTI  accounted  for  the  vast
majority  of  preterm  infants.
Several reports  indicate  an  increase  in  the  LPTI  over
time.  Davidoff  et  al.27 showed  a  change  in  the  mean  GA
at  birth  from  40  weeks  in  1992  to  39  in  2002,  among  all
spontaneous  deliveries  the  U.S.,  and  this  was  attributed
to  the  increase  in  the  rate  of  LPTI.  Yoder  et  al.28 found  a
37%  increase  in  the  proportion  of  LPTI  at  a  tertiary  center
in  the  U.S.,  from  1990-1998.
Part of  this  increase  was  due  to  the  rise  in  multiple
pregnancies  resulting  from  in  vitro  fertilization,  but  a
large  part  of  this  increase  was  probably  caused  by  an
increase  in  medical  interruption  of  pregnancy,  and  also
possibly  by  other  factors  that  are  yet  to  be  well  identified.
There are  no  data  on  the  frequency  of  LPTI  in  Brazil,
and there  is  even  difficulty  to  accurately  estimate  the
frequency  of  preterm  infants  as  a  whole,  due  to  the  low
reliability  of  data  on  GA.29 A  recent  review  found  rates  for
overall  prematurity  up  to  15%  in  the  South  and  Southeast
(1978-2004) and  up  to  10.2%  in  the  Northeast  (1984-1998),
but failed  to  obtain  data  from  the  North  and  Midwest
regions.30
)  Causal  and  associated  conditions:  the  causes  of  spon-
taneous  birth  in  LPTI  probably  do  not  differ  very  much
from  causes  in  lower  GAs,  including  the  fact  that,  in  most
cases,  they  are  not  known.  Hiltunen  et  al.31 demonstrated
that when  the  mother  is  a  carrier  of  factor  V  Leiden,  the
risk  of  late  prematurity  increases,  but  not  that  of  early
prematurity.  However,  this  condition  is  probably  associ-
ated  with  a  small  part  of  these  births.  Santos  et  al.,11
in  Brazil,  observed  an  association  between  late  prema-
turity  and  maternal  age  younger  than  20  years,  with  aMachado  LC  Jr  et  al.
prevalence  ratio  (PR)  of  1.3  (95%  CI:  1.1-1.6),  and  also
with  lack  of  prenatal  care,  PR  2.4,  (95%  CI:  1.4-4.2).
An important  aspect  is  to  know  the  proportion  of
LPTI births  resulting  from  medical  interruption  of  preg-
nancy  and  the  specific  indications  for  such  interruptions.
Laughon et  al.32 reported  29.8%  of  cases  resulted  from
spontaneous  deliveries,  32.3%  from  premature  rupture  of
membranes  (PROM),  31.8%  from  medical  interruptions,
and 6.1%  from  undocumented  causes.  Gyamfi-Bannerman
et al.33 found  32.3%  of  births  due  to  medical  inter-
ruption.  In  this  group,  56.7%  of  the  interruptions  were
decided  due  to  reasons  not  based  on  scientific  evidence.
Of  these,  80.3%  had  private  health  insurance  versus
59% in  the  group  with  well-based  interruptions  (p  <
0.001).  Reddy  et  al.34 reported  a  49%  rate  of  sponta-
neous  births  (excluding  PROM)  and  23.2%  of  interruptions
‘‘with no  recorded  indications’’.  Holland  et  al.35 found
36%  of  spontaneous  births  (also  without  PROM)  and  17%  of
interruptions  they  classified  as  ‘‘potentially  avoidable’’,
including, in  the  latter  group,  8.2%  of  ‘‘elective  inter-
ruptions’’,  that  is  to  say,  interruptions  ‘‘with  no  medical
indication’’.
In  the  last  two  studies,  interruptions  ‘‘with  no  recorded
indications’’ or  ‘‘potentially  avoidable’’  were  associated
with  private  medical  care.  In  the  majority  of  Brazilian
public  hospitals  there  is  no  pregnancy  interruption  upon
request  by  the  patient  or  at  the  physician’s  convenience,
or, at  least,  there  is  no  provision  for  these  situations.
However, there  is  a  high  frequency  of  pregnancy  inter-
ruptions  in  the  Brazilian  private  sector,  often  by  cesarean
section.36 It  is  possible  that  part  of  these  interruptions
occur in  the  range  of  late  preterm  infants.
) Neonatal  morbidity:  Many  studies  have  addressed
complications in  preterm  infants  when  compared  with
those  born  at  term.  All  studies  observed  higher  morbid-
ity  in  the  preterm  group  regarding  one  or  more  aspects,
with  statistical  significance.  Most  of  these  studies  per-
formed  adjustment  for  confounding  variables.  Many  of
them  excluded  multiple  and  high  risk  pregnancies,  as  well
as  malformations.
The  main  morbidity  conditions  studied  were:  respi-
ratory,  metabolic,  sepsis,  intraventricular  hemorrhage,
necrotizing enterocolitis,  susceptibility  to  infection  by
respiratory  syncytial  virus  (RSV),  admission  to  NICU,  and
prolonged  hospitalization.  Table  1  summarizes  the  find-
ings  of  the  selected  studies  on  morbidity11,13,14,37--40 and
describes the  most  important  aspects  of  their  design.
Boyce  et  al., 41 observed  a  rate  of  hospitalization  for
RSV  infection  in  the  first  year  of  life  of  66:1,000  for
children  between  29  and  32  weeks,  57:1,000  for  those
between  33  and  37  weeks,  and  30:1,000  for  those  born  at
term.  Horn  et  al.42 studied  the  evolution  during  hospital-
ization for  RSV  infection  in  the  first  year  of  life,  stratified
by GA  at  birth.  They  found  an  increased  frequency  of  oro-
tracheal  intubation  (p  =  0.002)  and  longer  duration  of
hospitalization  (p  <  0.0001)  in  infants  born  between  33
and  35  weeks  versus  36  or  more.
) Mortality:  all  studies  that  addressed  this  topic  observed
higher  neonatal  and  infant  mortality  in  LPTI  when  com-
pared  to  those  born  at  term.  The  studies  by  Guasch
et al.,25 Teune  et  al.,14 Kramer  et  al.,43 Crump  et  al.,44
Santos  et  al.,11 and  Araújo  et  al.13 are  summarized
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Table  1  Neonatal  complications  in  late  preterm  infants  compared  with  those  born  at  term:  effect  or  association  measures  and  95%  confidence  intervals.
Complications  Authors
Hernández-
Díaz
et  al.38, a
OR  (95%  CI)
Santos
et  al.11, b
RR  (95%  CI)
Melamed
et al.40, c
%  (p)
Dani
et  al. 39,  d
RR  (95%  CI)
Consortium  on
Safe Labor
et al.,37, e
OR  (95%  CI)
Teune
et al. 14,  f
RR  (95%  CI)
Araújo
et al. 13,  d
OR  (95%  CI)
Hyaline  membrane 4.2  x  0.1 (< 0.001) 7.5 (3.4--16.7) 40.1  (32.0--50.3) 17.3  (9.8--30.6) 4.0  (3.6--4.5)
Transient tachypnea 8.6  x  0.9 (< 0.001) 14.7  (11.7--18.8) 48.5  (19.3--122.5)
Pulmonary hypertension 3.7  (2.3--6.0) 0.2  x  0.03 (< 0.02)
Pneumonia 0.7  x  0.1 (< 0.001) 7.6  (5.2--11.2) 4.3  (1.6--11.5)
Apnea 1.8  x  0.2 (< 0.001) 15.7 (11.8--20.9) 23.3  (5.3--102.6)
Pneumothorax 1.0  x  0.1 (< 0.001) 3.4 (1.8--6.4)
Septicemia 0.4  x  0.04 (< 0.001) 5.6 (1.3--24.2)
Intraventricular  hemorrhage  0.2  x  0.02  (<  0.001)  4.9  (2.1--11.7)
Necrotizing enterocolitis  7.5  (3.3--17.3)
Jaundice with  phototherapy  18  x  2.5  (<  0.001)  3.0  (2.2--4.0)  5.0  (1.7--14.6)
Hypoglycemia 6.8  x  0.4  (<  0.001)  12.4  (10.1--15.4)  7.4  (3.0--18.1)  5.9  (3.6--9.5)
Hypocalcemia 13.2  (4.8--36.5)
Hypothermia 0.7  x  0.1  (<  0.001)  10.8  (4.6--25.0)
Feeding difficulties  2.7  (1.2--6.2)  6.5  (2.5--16.9)
Need for  neonatal  resuscitation  2.3  (1.5--2.4)
Apgar <  7  at  the  5th  minute  2.6  (1.4--4.9)  2.7  (1.1--6.5)
Overall neonatal  morbidity  2.8  (2.3--3.5)
Neonatal ICU  admission  1.6  (1.2--2.1)  19.7  x  2.8  (<  0.001)  19.8  (8.7--44.8)  25.2  (16.2--39.1)
Prolonged hospitalization  18.7  x  1.9  (<  0.001)  3.5  (2.8--4.4)
CI, confidence interval; ICU, intensive care unit; OR, odds ratio; RR, relative risk.
Obs.: all studies shown in the table are observational.
a malformations were excluded, but risk pregnancies or multiple gestations were not excluded; control for confounding variables was performed, including multiple gestations.
b malformations or risk pregnancies were not excluded, but multiple gestations were excluded and control for confounding variables was performed.
c malformations and risk pregnancies, multiple gestations, several indications for cesarean section and all forceps births were excluded; control for confounding variables was performed.
d malformations, risk pregnancies or multiple gestations were not excluded and control for confounding variables was  not performed.
e multiple gestations, high-risk pregnancies or malformations were not excluded; control for confounding variables was performed, including for malformations and multiple gestations.
f meta-analysis study.
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Table  2  Mortality  among  late  preterm  infants  when  compared  with  infants  born  at  term:  effect  measures  and  95%  confidence
intervals.
Authors  Outcome
Neonatal  Mortality  Mortality  in  the
first year  of  life
Mortality  in  young
adult age
(18 to  36  years)
Kramer  et  al.43 (USA)a OR  2.9  (2.8--3.0)  -  -
Kramer  et  al., 43 (Canada)a OR  4.8  (4.0--5.0)  -  -
Santos  et  al.11,  b RR  5.1  (1.7--14.9)  RR  2.1 (1.0--4.6)  -
Guasch  et  al., 25,c OR  4.7  (2.3--9.5)  -  -
Crump  et  al.44,a -  -  HR  1.3  (1.1--1.5)
Teune et  al.14,d RR  5.9  (5.0--6.0)  RR  3.7 (2.9--4.6)  -
Araújo  et  al.13,c OR  9.1 (2.4--33.9) -  -
HR, hazard ratio; OR, odds ratio; RR, relative risk.
Obs.: all studies shown in the table are observational.
a malformations or risk pregnancies were not excluded, but multiple gestations were excluded; control for confounding variables was
performed, including malformations.
b malformations or risk pregnancies were not excluded, but multiple gestations were excluded; control for confounding variables was
performed.
ot ex
f
gc malformations, risk pregnancies, or multiple gestations were n
d meta-analysis study.
in  Table  2,  which  also  summarizes  the  most  important
aspects  of  their  design.  Crump  et  al.44 demonstrated  that
this  higher  mortality  is  maintained  in  the  first  five  years
of  life,  disappears  during  childhood  and  adolescence,  and
reappears  in  young  adults.
Pulver et  al.45 compared  neonatal  and  infant  mortality
in LPTI  versus  those  born  at  term  (39  to  42  weeks),  consid-
ering  the  weight/GA  ratio.  After  exclusion  of  congenital
diseases, they  observed  a  RR  of  14.2  (95%  CI:  4.1-49.1)
for neonatal  death  in  female  LPTIs  who  were  small  for
GA  when  compared  to  full-term  female  infants  appropri-
ate  for  GA.  The  LPTIs  that  were  appropriate  for  GA  also
had  high  risk  in  the  same  comparison  (RR:  4.1;  95%  CI:
1.7-9.6).  They  found  similar  results  for  infant  mortality.
They  concluded  that  LPTIs  that  are  small  for  GA  consti-
tute  a  group  with  particularly  increased  risk  for  neonatal
and  infant  death.  McIntire  et  al.24 compared  the  neona-
tal  mortality  of  34  to  42  weeks  of  GA,  using  mortality
at 39  weeks  as  reference,  which  was  the  lowest  in  the
study  population.  They  found  significantly  higher  mor-
tality  that  had  a  trend  of  decrease  compared  to  that  of
the  reference  up  to  the  37  week.  These  authors  included
only low-risk  pregnancies,  excluded  malformations,  and
performed  adjustments  for  confounding  variables.
) Long-term  effects:  Raby  et  al.46 studied  a  cohort  in
Boston,  USA.  They  compared  children  born  between  36
and  38.5  weeks  who  had  no  malformations,  were  not
admitted  to  NICU,  and  had  no  respiratory  infection  in  the
first  year  of  life,  with  controls  born  between  38.6  and
40  weeks.  At  6  years,  the  first  group  had  a  higher  risk  of
asthma,  compared  to  the  second  (adjusted  OR:  5.6;  95%
CI:  2.5-12.38).  Woythaler  et  al.47 observed  a  higher  fre-
quency  of  delayed  mental  development  at  2  years  (OR:
1.52;  95%CI:  1.26-1.82)  and  delayed  psychomotor  devel-
opment  (OR  1.56;  95%  CI:  1.30-1.89)  in  LPTIs  compared
to  infants  born  at  term.cluded, control for confounding variables was not performed.
In  Brazil,  Santos  et  al.48 showed  higher  frequency  of
inadequate  growth  at  2  years  (OR:  2.30;  95%  CI:  1.40-
3.77).  Peacock  et  al.49 studied  performance  in  regular
preschool tests,  comparing  infants  born  between  32  and
37  weeks  to  full-term  infants.  They  found  a  lower  fre-
quency  of  good  performance  among  preterm  infants
(adjusted OR:  0.74;  95%  CI:  0.59-0.92).  Teune  et  al.14
found  greater  risk  for  cerebral  palsy  (RR  3.1;  95%  CI:  2.3-
4.2)  and  mental  retardation  (RR:  1.5;  95%  CI:  1.2-1.9).
Moster et  al.50 reported  an  increased  risk  of  schizophrenia
(RR: 1.4;  95%  CI:  1.1-1.8)  and  a  lower  proportion  of  young
individuals  who  finished  college/university  (OR:  0.87;  95%
CI:  0.84-0.89).  Teune  et  al.14 found  a  lower  chance  of  fin-
ishing  high  school  (RR:  0.96;  95%  CI:  0.95-0.97).  Crump
et  al.,51 in  a  study  of  nearly  650,000  newborns  in  Sweden,
found an  association  between  prematurity  and  diabetes  in
young  adults  (25  to  37  years),  including  those  born  from  35
to  36  weeks.  For  this  range,  they  found  a risk  for  diabetes
of any  type  (adjusted  OR:  1.18;  95%  CI:  1.04-1.33)  and
type  I  diabetes  (adjusted  OR:  1.22;  95%  CI:  1.05-1.42).
) Re-hospitalizations  and  costs:  Bird  et  al.52 found  higher
costs  for  the  healthcare  system  for  LPTIs  in  the  first  year
of  life.  The  mean  difference  (adjusted  values)  was  U$
108  for  outpatient  care  (95%  CI:  58-158)  and  U$  597  for
hospital  care  (95%  CI:  528-666)  for  each  child,  when  com-
pared  with  infants  born  at  37  to  42  weeks.  McIntire  et  al.24
found  mean  hospital  costs  of  US$  6,094  for  each  neonate
at  34  weeks  and  US$  2,019  for  children  born  at  36  weeks,
versus  US$  1,258  for  those  born  at  39  weeks  (p  <  0.001).
Jain  et  al.53 reported  that  17.7%  of  emergency  room  visits
in  the  first  31  days  of  life  consisted  of  LPTI,  when  com-
pared  with  the  national  mean  of  8.8%  in  the  United  States
for  births  at  this  GA.  Escobar  et  al.54 found  more  re-
hospitalizations  between  15  and  182  days  in  neonates
born at  36  weeks  when  compared  with  those  born  at  38
to  40  weeks  (RR:  1.67;  95%  CI:  1.23-2.25).
h•
•Late  prematurity  
Murthy  et  al.,55 in  Illinois,  United  States,  observed
a historical  increase  in  the  frequency  of  labor  induc-
tions between  34  and  37  weeks:  5.4:1,000  in  1991  to
15.2:1,000  in  2003  (p  <  0.001).  They  also  observed  an
increase  in  legal  suits  for  medical  malpractice,  which
they  considered  to  be  associated  with  increased  induction
(p  =  0.004).
)  Breastfeeding:  a  higher  frequency  of  difficulties  in
LPTI  breastfeeding  has  been  documented,  such  as  early
weaning,  poor  growth,  and  dehydration,  as  well  as  breast-
feeding  jaundice.56
i)  Strategies  to  address  the  problem:  the  relevance  of  the
increased  risks  for  LPTI,  as  demonstrated  above,  is  widely
documented  and  studies  have  been  performed  to  evalu-
ate  possible  strategies  to  address  the  matter.
The  following  should  be  considered:
1)  Attempted  tocolysis:  Most  obstetrics  services  perform
tocolysis up  to  33  weeks  and  six  days  of  gestation.57
There  is  evidence  of  little  benefit  in  neonatal  outcomes
with tocolysis.58 Part  of  this  benefit  is  attributed  to  the
extra  time  of  gestation  obtained  for  the  action  of  corti-
costeroids  given  to  the  mother  to  accelerate  fetal  lung
maturity.  It  is  unclear,  however,  whether  these  benefits
extend  to  the  age  range  of  the  LPTI.  It  is  possible  that
the non-performance  of  tocolysis  after  34  weeks  is  partly
due  to  the  fact  that  corticosteroids  are  usually  not  used
during  this  period.  New  studies  on  tocolysis  in  this  group
are  needed.
2)  Review  pregnancy  interruption  routines:  the  decision  to
perform  the  delivery  before  spontaneous  labor  onset,
either  by  labor  induction  or  cesarean  section,  is  a  fre-
quent  situation  in  obstetrics.  For  each  condition,  the
physician  attempts  to  assess  the  risk  of  maintaining  the
pregnancy  versus  the  risks  associated  with  induction  and
with  cesarean  section,  when  induction  fails  or  when  it  is
contraindicated.  Moreover,  and  more  importantly,  when
it  is  decided  to  interrupt  the  pregnancy  before  term,
the  maternal  and/or  fetal  risk  of  maintaining  the  preg-
nancy  versus  the  risk  of  prematurity  is  evaluated.  This
assessment  is  complex  and  is  subject  to  errors,  as  any
risk  assessment.  The  knowledge  that  the  risks  of  birth
between  34  and  37  weeks  are  higher  than  previously
understood  could  change  the  traditionally  standardized
conduct in  some  clinical  situations,  such  as:
• Preterm  premature  rupture  of  membranes  (PPROM):  it  is
quite  common  in  the  obstetrics  services  to  interrupt  preg-
nancy  in  the  presence  of  PPROM  from  34  weeks  on,  with  or
without  lung  maturity  assessment.59 Recent  studies,  how-
ever,  have  questioned  this  practice.  A  Cochrane  Library
review60 focused  on  the  expectant  management  versus
interruption  in  pregnancies  lasting  less  than  37  weeks.
They  found  no  significant  differences  in  both  the  neonatal
and  maternal  outcomes.  Mateus  et  al.61 observed  a  higher
frequency  of  hyaline  membrane  disease  in  women  with
PPROM  who  had  the  pregnancy  interrupted  at  34  weeks,
when  compared  to  those  interrupted  at  35  weeks  (RR:
3.4;  95%  CI:  1.5-7.7)  and  36  weeks  (RR:  8.6;  95%  CI:  2.7-
27.5).  They  also  observed  significant  differences  in  the227
same  comparisons  for  NICU  admission  and  length  of  hospi-
talization.  The  interruptions  were  performed  electively,
i.e.,  in  the  absence  of  infection  or  other  events  rather
than  PPROM.  There  were  no  cases  of  sepsis  in  this  series
of  192  cases.
A recent  clinical  trial:62 PPROM  Expectant  Management
versus Induction  of  Labor  (PPROMEXIL)  of  536  pregnant
women between  34  and  37  weeks  of  GA  compared  inter-
ruption  by  induction  or  cesarean  section  (due  to  obstetric
indications)  24  hours  after  the  rupture  versus  expectant
management while  monitoring  for  infection,  up  to  37
weeks  of  GA.  They  found  no  significant  differences  for
neonatal  sepsis.  However,  a  higher  incidence  of  hypo-
glycemia  (RR:  2.16;  95%  CI:  1.36-3.43)  and  jaundice  (RR:
1.47;  95%  CI:  1.13-1.90)  was  observed  in  the  interrup-
tion  group.  An  extension  of  this  study63 with  200  pregnant
women  showed  similar  results,  even  when  the  data  were
analyzed  together  with  those  from  the  previous  study.
There  is  currently  another  ongoing  clinical  trial64 with
the  same  goal:  Preterm  Prelabour  Rupture  Of  the  Mem-
branes  close  to  Term  (PPROMT),  comprising  approximately
1,800 pregnant  women.  The  authors  of  the  PPROMEXIL62
study  believe  that,  even  if  the  PPROMPT  study  or  a  meta-
analysis  including  this  and  other  clinical  trials  show  a
significant  difference  in  relation  to  neonatal  sepsis,  this
difference  would  not  be  clinically  relevant,  as  the  inci-
dence  of  this  complication  was  very  small  (1.1%  in  the
expectant  group  versus  0.4%  in  the  interruption  group
in  the  PPROMEXIL  study).  The  authors  attribute  this  low
incidence  to  the  most  frequent  contemporary  use  of
prophylactic  antibiotics  in  cases  of  PPROM.  They  also
attribute  to  this  use  the  difference  in  the  results  of
current  studies  when  compared  to  previous  studies  per-
formed  with  the  same  objective.
 Restricted  fetal  growth  and  oligohydramnios: Galan65
proposes  for  cases  of  restricted  fetal  growth,  when
there is  no  change  in  the  assessments  of  fetal  well-being
or other  changes  that  justify  early  interruption,  that
the  latter  take  place  between  37  and  38  weeks.  This
author  proposes  the  same  conduct  in  cases  of  isolated
oligohydramnios without  PPROM.  Baschat66 performed
an extensive  review  of  restricted  fetal  growth.  He
emphasizes that  currently,  two  types  of  presentation
of this  condition  can  be  identified:  one  of  early  onset,
detectable  before  34  weeks,  and  another  that  is  detected
after  this  age.  According  to  this  author,  in  cases  of  late
onset,  neurological  and  cognitive  sequelae  detected  in
the  long  term  are  associated  mainly  with  compensatory
circulatory changes  of  hypoxemia,  usually  detected  by
Doppler  velocimetry,  especially  in  the  middle  cerebral
artery. It  can  then  be  assumed  that,  in  the  absence  of
these  changes,  under  careful  surveillance,  it  would  be
acceptable  to  wait  until  the  pregnancy  aproaches  or
reaches  term.
 Diabetes  in  pregnancy: Catalano  and  Sacks67 state  that
the best  time  to  interrupt  the  pregnancy  in  several  clini-
cal  diabetes  situations  remains  a  controversial  matter  and
that  clinical  trials  are  needed  in  order  to  define  these
practices on  a  more  robust  basis.  Vignoles  et  al.68 stud-
ied  cases  of  severe  respiratory  failure  in  newborn  infants
of  diabetic  mothers  who  delivered  after  34  weeks.  In  the
multivariate  analysis,  they  found  prematurity  (OR:  6.13;
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95%  CI:  1.8-21.2)  and  gestational  diabetes  (OR:  11.55;  95%
CI:  3.9-33.9)  as  independent  risk  factors  for  this  compli-
cation.
 Preeclampsia:  there  is  a  reasonable  consensus  that  it  is
not advisable  to  wait  for  the  end  of  pregnancy  in  the  pres-
ence  of  preeclampsia.  It  remains  unclear,  however,  what
is  the  best  time  to  interrupt  the  pregnancy  in  cases  with
mild  preeclampsia.  It  is  necessary  to  assess  the  risk  of
maternal  and  fetal  worsening  versus  the  risks  of  prematu-
rity.  There  is  an  ongoing  clinical  trial  comparing  outcomes
of  expectant  management  versus  interruption  in  LPTI.69
)  Consider  the  use  of  corticosteroids:  There  is  evidence  of
benefits  regarding  the  use  of  corticosteroids  for  induc-
tion  of  fetal  lung  maturity  up  to  34  weeks,  with  no  clear
benefits  above  this  age.  Similarly  to  tocolysis,  it  is  com-
mon  practice  to  restrict  the  use  of  corticosteroids  up  to
34  weeks.70
Some  observational  studies  suggest  benefits  of  this
practice  in  LPTI,  with  reduced  respiratory  morbidity71
(OR:  0.39)  and  overall  morbidity72 (OR:  0.24).  A  clini-
cal trial  performed  in  Turkey  showed  decreased  hyaline
membrane  disease  and  need  for  neonatal  resuscitation.73
A  clinical  trial  in  Brazil  showed  no  benefits  for  respiratory
morbidity, but  observed  a  lower  proportion,  although  not
significant,  of  overall  morbidity  in  cases  who  received
corticosteroids: 62%  in  treated  cases  versus  72%  in  the
control  group  (p  =  0.08).12
Another  clinical  trial  observed  fewer  NICU  admissions
in  neonates  born  at  term  from  cesarean  sections  with-
out  labor  and  whose  mothers  received  this  medication.74
Further  clinical  trials  are  needed  for  this  purpose.
) Changes  in  neonatal  routines:  for  instance,  more  restric-
tiveness regarding  the  choice  of  rooming-in  or  low  risk
nursery,2 as  well  as  in  early  discharge.3 Based  on  their
study  of  neonates  with  kernicterus,  Bhutani  &  Johnson75
emphasize  that  a  large  number  of  preterm  infants  who
developed  this  complication  were  discharged  early,  and
in  most  cases,  the  risk  factors  for  this  complication  were
not  taken  into  account,  among  these,  prematurity.
iscussion
any  studies  show  higher  mortality  and  higher  frequency  of
everal complications  in  preterm  infants  when  compared  to
ull-term infants.  This  difference  is  statistically  significant
nd clinically  relevant  in  most  of  the  comparisons.  It  is  note-
orthy that  some  studies  observed  an  association  not  only
ith death  and  neonatal  problems,  but  also  with  diseases
nd sequelae  that  manifest  in  the  long-term.  The  argument
hat these  associations  are  confounded  by  the  higher  fre-
uency of  conditions  found  in  LPTI  that  worsen  the  prognosis
hemselves, such  as  maternal  illnesses,  PPROM,  malforma-
ions, etc.,  is  weak,  as  most  studies  excluded  or  performed
djustments for  these  conditions.
The  findings  of  the  studies  by  Goldenberg  et  al.4 and  De
alma et  al.5 are  probably  valid.  Their  particularity  is  that
omparisons were  made  only  within  the  group  of  prema-
ure infants.  When  comparing  the  preterm  neonates  with
nfants born  at  term,  which  was  performed  in  more  recent
tudies, it  was  observed  that  the  former  have  a  risk  of  death
t
t
pMachado  LC  Jr  et  al.
nd  complications  that  is  higher  and  great  for  contemporary
tandards.
It appears  that  the  need  for  confirmation  of  the  con-
istency and  magnitude  of  these  associations  (late  preterm
irth and  unwanted  outcomes)  has  lessened,  and  that  it  is
ecessary to  shift  resources  to  the  evaluation  of  the  pro-
osed strategies  for  addressing  this  problem.  As  discussed
bove, both  clinical  trials  and  observational  studies  are
eeded with  this  group  of  patients,  covering  aspects  such  as
se of  antenatal  corticosteroids,  attempted  tocolysis,  and
eassessment of  routines  for  the  interruption  of  high-risk
regnancies. Proposals  for  increased  neonatal  surveillance
or these  infants  are  also  expected.
The  recently  published  studies  by  Lisinkova  et  al.20 and
oseph et  al.22 may  be  the  subject  of  considerable  contro-
ersy. However,  the  points  of  view  presented  by  the  authors
ould apply  primarily  to  deliveries  resulting  from  medical
nterruption. The  increased  risk  of  preterm  infants  com-
ared to  those  born  at  term,  however,  is  not  limited  to
igh-risk pregnancies  or  medical  interruptions.  Many  of  the
tudies included  only  low-risk  pregnancies,24,40 and  even
hese showed  a  major  association  with  complications  and
eaths. Furthermore,  in  most  series,  the  majority  of  late
reterm newborns  were  the  result  of  spontaneous  deliver-
es.
Of the  abovementioned  strategies  to  address  the  issue  of
ate preterm  birth,  only  the  revaluation  of  medical  interrup-
ion could  be  questioned,  if  these  authors’  arguments  are
onsidered. However,  even  the  arguments  on  interruption
an be  questioned.  The  limitations  of  ecological  studies  are
ell known,76 as  they  compare  different  populations  and,
herefore, the  analyses  are  not  performed  on  an  individual
asis. It  is  uncertain,  for  instance,  whether  the  children  who
id not  die  during  intrauterine  life  or  in  the  neonatal  period
n populations  with  higher  rates  of  late  preterm  birth  are
recisely those  whose  pregnancy  was  interrupted  between
2 and  37  weeks.
One  possibility  that  cannot  be  ignored  is  that  the  lower
umber of  stillbirths  and  neonatal  deaths  is  due  to  overall
etter quality  of  obstetric  and  neonatal  care  in  these  popu-
ations, and  that  the  higher  availability  of  maternal  and  fetal
onitoring methods  leads,  in  parallel,  to  a  higher  rate  of
nterruption before  term;  this  higher  rate  would  result  in  a
elative worsening  of  the  outcomes.
Another  possibility  is  that  the  results  are  due  in  part
o the  higher  rate  of  interruptions  and,  in  part,  to  better
verall care;  the  result  attributed  by  authors  to  the  first
omponent would  be  then  ‘‘contaminated’’  by  the  perfor-
ance of  the  second  component.  Nevertheless,  the  proposal
f not  interrupting  any  gestation  before  37  weeks  has  never
een suggested.  The  emphasis,  taking  into  account  the
nowledge added  by  the  studies  discussed  in  this  study,  is
hat, when  comparing  the  risks  of  maintaining  the  pregnancy
ith those  of  prematurity,  pregnancies  between  34  and  37
eeks should  not  be  considered  as  ‘‘virtually  at  term’’  (and
onsequently, that  there  is  no  benefit  in  extending  them),
nd each  clinical  case  should  be  analyzed  on  an  individual
asis.A modality  of  late  preterm  birth  that  is  probably  impor-
ant in  Brazil,  although  it  also  occurs  in  other  countries,  is
hat resulting  from  personal  (whether  from  the  patient  or
hysician), non-medical  reasons,  which  lead  to  pregnancy
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interruption.  It  is  possible  that  this  type  of  interruption
occurs more  often  at  the  full  37  weeks,  which  is,  by  defi-
nition, a  term  pregnancy,  but  still  with  higher  morbidity  and
mortality when  compared  with  39  weeks.24
As  discussed33--36 in  the  ‘‘causal  and  associated  condi-
tions’’ section,  this  type  of  situation  occurs  more  often  in
the private  healthcare  sector.  It  is  difficult  to  estimate  the
exact frequency  of  this  type  of  interruption,  as  it  is  com-
mon for  the  motivation  not  to  be  explicitly  documented,
but rather  justified  under  other  diagnoses  or  indications.
Similarly, a  policy  of  hospitals  to  reduce  this  practice  would
have limited  results;  first,  due  to  the  difficulty  of  identifying
cases, and  second,  due  to  the  difficulty  of  standardization  of
private medical  activity.  The  authors  believe,  however,  that
part of  the  trend  for  this  practice  among  some  professionals
is due  to  the  assumption  that  it  does  not  have  major  conse-
quences. It  can  therefore  be  expected  that  the  disclosure  of
the results  of  more  recent  studies,  such  as  those  discussed
above, may  change  certain  practices,  at  least  in  part.
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